ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VNDA Vanda Pharmaceuticals Inc

6.13
-0.14 (-2.23%)
After Hours
Last Updated: 18:34:50
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.14 -2.23% 6.13 18:34:50
Open Price Low Price High Price Close Price Previous Close
6.23 6.09 6.43 6.12 6.27
more quote information »

Recent News

Date Time Source Heading
6/06/202415:30EDGAR2Form 8-K - Current report
6/06/202408:24PRNUSVanda Pharmaceuticals Confirms Receipt of Unsolicited,..
5/30/202416:20PRNUSVanda Pharmaceuticals Announces Participation in the..
5/30/202415:48PRNUSVanda Pharmaceuticals Announces Completion of Transfer of..
5/29/202413:17PRNUSVanda Pharmaceuticals Announces Presentations at SLEEP 2024
5/24/202415:49EDGAR2Form 8-K - Current report
5/24/202415:46PRNUSVanda Pharmaceuticals Board of Directors Determines that..
5/24/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:31EDGAR2Form 8-K/A - Current report: [Amend]
5/21/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/20/202416:26EDGAR2Form 8-K - Current report
5/15/202407:45PRNUSVanda Pharmaceuticals Reports Positive Results from a Second..
5/13/202415:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/09/202416:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/09/202406:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:06EDGAR2Form 8-K - Current report
5/08/202415:01PRNUSVanda Pharmaceuticals Reports First Quarter 2024 Financial..
5/07/202415:51EDGAR2Form 8-K - Current report
5/07/202410:16PRNUSVanda Pharmaceuticals Confirms Receipt of Revised..
4/30/202415:30PRNUSVanda Pharmaceuticals to Announce First Quarter 2024..
4/25/202407:05GLOBEShareholder Capital Delivers Letter to Independent Members..
4/22/202418:13PRNUSVanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial..
4/17/202409:21PRNUSVanda Pharmaceuticals Adopts Limited Duration Stockholder..
4/17/202408:02PRNUSVanda Pharmaceuticals Confirms Rejection of Unsolicited..
4/03/202409:25APSBiotech Catches Major Premarket Bid Following FDA Approval
4/02/202417:10PRNUSVanda Pharmaceuticals' FanaptĀ® (iloperidone) Receives U.S...
3/07/202415:31EDGAR2Form 8-K - Current report
3/06/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202406:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
3/04/202420:14EDGAR2Form 144 - Report of proposed sale of securities
3/04/202420:12EDGAR2Form 144 - Report of proposed sale of securities
3/04/202420:10EDGAR2Form 144 - Report of proposed sale of securities
3/04/202420:08EDGAR2Form 144 - Report of proposed sale of securities
3/04/202420:06EDGAR2Form 144 - Report of proposed sale of securities
2/21/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:32EDGAR2Form 8-K - Current report
2/16/202415:31EDGAR2Form 8-K/A - Current report: [Amend]
2/08/202406:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/07/202415:07EDGAR2Form 8-K - Current report